Ampio Pharma (AMPE) –
-
Ampio Pharma (AMPE) Announces Voluntary Delisting
-
Ampio Announces Voluntary Delisting and SEC Deregistration
-
Ampio Pharma (AMPE) Provides Update on Results from Pre-IND Enabling Studies
-
Ampio Provides Update on Results from Pre-IND Enabling Studies
-
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions
-
Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now
-
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
-
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
-
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
-
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
-
Ampio Pharma (AMPE) Files $50M Mixed Shelf
-
Ampio Pharma (AMPE) Announces 1:20 Reverse Stock Split
-
Ampio Pharmaceuticals Announces Reverse Stock Split
-
Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock
-
Ampio Pharma (AMPE) Issues Letter to Shareholders
-
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
-
Ampio Pharma (AMPE) CEO Issues Letter to Shareholders
-
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
-
Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards
-
Ampio Pharma (AMPE) Announces NYSE American Removal of Trading Suspension
-
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension
-
Form 10-Q Ampio Pharmaceuticals, For: Sep 30
-
Form 8-K Ampio Pharmaceuticals, For: Nov 08
-
Ampio Pharma (AMPE) Announces 15:1 Reverse Stock Split
-
Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split
-
Form 8-K Ampio Pharmaceuticals, For: Oct 13
-
Ampio Pharma (AMPE) Issues Letter to Shareholders
-
Ampio Pharmaceuticals Issues Letter to Stockholders
-
Form DEFA14A Ampio Pharmaceuticals,
-
Form DEFA14A Ampio Pharmaceuticals,
-
Ampio Pharma (AMPE) Issues Letter to Stockholders, Calls for Reverse Stock-split
-
Ampio Pharmaceuticals Issues Letter to Stockholders
-
Form 8-K Ampio Pharmaceuticals, For: Oct 03
-
Ampio Pharma (AMPE) Announces NYSE American Has Commenced Delisting Proceedings
-
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
-
Ampio Pharma (AMPE) halted, news pending
-
Form DEF 14A Ampio Pharmaceuticals, For: Oct 13
-
Form 8-K Ampio Pharmaceuticals, For: Aug 30
-
Form PRE 14A Ampio Pharmaceuticals, For: Oct 13
-
Form 8-K Ampio Pharmaceuticals, For: Aug 10
-
Form 10-Q Ampio Pharmaceuticals, For: Jun 30
-
Form DEFA14A Ampio Pharmaceuticals,
-
Form DEFA14A Ampio Pharmaceuticals,
-
Form 8-K Ampio Pharmaceuticals, For: Aug 02
-
Ampio Pharma (AMPE) CEO Issues Letter to Shareholders
-
Ampio Pharmaceuticals Issues Letter to Stockholders
-
Form SC 13G Ampio Pharmaceuticals, Filed by: BlackRock Inc.
-
Form DEFA14A Ampio Pharmaceuticals,
-
Form DEF 14A Ampio Pharmaceuticals, For: Aug 10
-
Ampio Pharma (AMPE) Granted US Patent #11369598 for "TREATMENT OF T-CELL MEDIATED DISEASES" Patent Stocks
Back to AMPE Stock Lookup